Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GARTENHAUS, R. B")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 13 of 13

  • Page / 1
Export

Selection :

  • and

Allelic loss determination in chronic lymphocytic leukemia by immunomagnetic bead sorting and microsatellite marker analysisGARTENHAUS, R. B.Oncogene (Basingstoke). 1997, Vol 14, Num 3, pp 375-378, issn 0950-9232Article

Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-1 transformed human T lymphocytesGARTENHAUS, R. B; WANG, P.Leukemia. 1995, Vol 9, Num 12, pp 2082-2086, issn 0887-6924Article

The promoter of human T-cell leukemia virus type-I is repressed by the immediate-early gene region of human cytomegalovirus in primary blood lymphocytesGARTENHAUS, R. B; WONG-STAAL, F; KLOTMAN, M. E et al.Blood. 1991, Vol 78, Num 11, pp 2956-2961, issn 0006-4971Article

Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cellsDIEROV, J; SAWAYA, B. E; PROSNIAK, M et al.Clinical cancer research. 1999, Vol 5, Num 9, pp 2540-2547, issn 1078-0432Article

Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanismPHATAK, P; COOKSON, J. C; DAI, F et al.British journal of cancer. 2007, Vol 96, Num 8, pp 1223-1233, issn 0007-0920, 11 p.Article

Expression of alternatively spliced human T-lumphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriersBERNEMAN, Z. N; GARTENHAUS, R. B; REITZ, M. S et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 7, pp 3005-3009, issn 0027-8424Article

Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotypeMAZAN-MAMCZARZ, K; HAGNER, P. R; CORL, S et al.Oncogene (Basingstoke). 2008, Vol 27, Num 47, pp 6151-6163, issn 0950-9232, 13 p.Article

PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21HU, F; GARTENHAUS, R. B; EICHBERG, D et al.Oncogene (Basingstoke). 2010, Vol 29, Num 40, pp 5464-5474, issn 0950-9232, 11 p.Article

A novel candidate oncogene, MCT-1, is involved in cell cycle progressionPROSNIAK, M; DIEROV, J; OKAMI, K et al.Cancer research (Baltimore). 1998, Vol 58, Num 19, pp 4233-4237, issn 0008-5472Article

Ribosomal protein S6 is highly expressed in non-Hodgkin lymphoma and associates with mRNA containing a 5' terminal oligopyrimidine tractHAGNER, P. R; MAZAN-MAMCZARZ, K; DAI, B et al.Oncogene (Basingstoke). 2011, Vol 30, Num 13, pp 1531-1541, issn 0950-9232, 11 p.Article

Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damageNAND, S; REINERT, L. S; HACHEM, A et al.Oncogene (Basingstoke). 2007, Vol 26, Num 16, pp 2283-2289, issn 0950-9232, 7 p.Article

The induction of p53 and WAF1/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosineGARTENHAUS, R. B; WANG, P; HOFFMAN, M et al.Journal of molecular medicine (Berlin. Print). 1996, Vol 74, Num 3, pp 143-147, issn 0946-2716Article

cDNA sequencing confirms HTLV-I expression in adult T-cell leukemia/lymphoma and different sequence variations in In vivo and In vitroBERNEMAN, Z. N; GARTENHAUS, R. B; REITZ, M. S et al.Leukemia. 1992, Vol 6, pp 67S-71S, issn 0887-6924, SUP3Conference Paper

  • Page / 1